Altamonte Springs, Fla.-based AdventHealth has expanded the footprint of its cancer institute with the opening of a new cancer center in Winter Garden, Fla. AdventHealth Winter Garden will begin treating patients at the new facility July 27, according to a…
Oncology
The FDA has granted full approval for selpercatnib in the treatment of advanced cancer among patients ages 2 and older who carry a rare genetic alteration. Selpercatinib, also known as Retevmo, targets and “turns off” the RET gene fusion to…
Abbott is investigating a cyber incident involving unauthorized access to a limited number of internal systems in its cancer diagnostics business. The incident does not affect business operations, product availability, manufacturing, lab operations or the company’s ability to serve patients,…
Boston-based Dana-Farber Cancer Institute, Columbus-based Ohio State University Comprehensive Cancer Center — James Cancer Hospital and Solove Research Institute, and the Inflammatory Breast Cancer Research Foundation have launched a joint research initiative on metastatic inflammatory breast cancer. The initiative will…
By decentralizing clinical trials, Rochester, Minn.-based Mayo Clinic increased enrollment of patients from rural communities and underserved racial and ethnic populations, according to a study published June 5 in JAMA Network Open. Mayo Clinic researchers evaluated data from 7,469 patients…
Advertisement
The University of Alabama at Birmingham has tapped Teviah Sachs, MD, as director for the division of surgical oncology. Dr. Sachs joins UAB from Boston University, where he served as chief of the section of surgical oncology, according to a…
Lexington-based University of Kentucky has topped off the new UK Cancer and Advanced Ambulatory Building. The building will be the new home of the UK Markey Cancer Center, as well as a spine center, ambulatory surgery space and other outpatient services, according…
New York City-based Weill Cornell Medicine has received a $2.5 million, three-year grant from the Defense Department to develop lower-side-effect therapies for triple-negative breast cancer. Triple-negative breast cancer lacks the estrogen receptor, progesterone receptor and HER2 proteins that many targeted…
An immunotherapy dosing program saved an estimated $296,000 in drug costs over 12 months at one VA medical center, according to a study published July 15 in NEJM Catalyst. Researchers at Ann Arbor, Mich.-based Charles S. Kettles VA Medical Center…
Financial conflicts of interest were present in the majority of cancer research reviewed in a study published July 15 in the Journal of the National Cancer Institute. Researchers from New Haven, Conn.-based Yale University reviewed 36 studies published since 2015…